Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Farallon has nominated three directors to the board of Exelixis, which develops cancer-fighting drugs.
Beijing is holding back its required green light for mergers that involve American companies as a technology war with Washington intensifies.
All those tech layoffs are starting to show up in employment statistics, but they still show little sign of spreading to other sectors.
Interest-rate increases and banking turmoil push down demand for multifamily buildings.
Prosecutors said the college financial-aid company executive lied about her customer count to land a $175 million deal.
The number of job openings fell below 10 million for the first time in nearly two years, a sign that employers’ demand for workers eased.
The centrak bank snapped a run of 10 consecutive rate increases, but said it is ready to resume tightening if price pressures intensify.
Crude futures extended gains, having posted their largest rise in more than a year Monday.
Geothermal energy has been a neglected corner of renewable energy because of its high cost and high risk profile.
Shareholders at the bank’s final annual meeting expressed their anger toward management and the board for failing to save the storied institution.
You can email us for any questions or concerns at any time. Our customer service staff will do their best to respond within 24 hours.